- Home
- DGICA vs PRTA Comparison
DGICA vs PRTA Comparison
Compare DGICA & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGICA
- PRTA
- Stock Information
- Founded
- DGICA 1986
- PRTA 2012
- Country
- DGICA United States
- PRTA Ireland
- Employees
- DGICA N/A
- PRTA N/A
- Industry
- DGICA Property-Casualty Insurers
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- DGICA Finance
- PRTA Health Care
- Exchange
- DGICA Nasdaq
- PRTA Nasdaq
- Market Cap
- DGICA 682.8M
- PRTA 809.8M
- IPO Year
- DGICA N/A
- PRTA N/A
- Fundamental
- Price
- DGICA $19.72
- PRTA $7.43
- Analyst Decision
- DGICA Hold
- PRTA Buy
- Analyst Count
- DGICA 1
- PRTA 9
- Target Price
- DGICA $18.00
- PRTA $51.71
- AVG Volume (30 Days)
- DGICA 119.7K
- PRTA 1.4M
- Earning Date
- DGICA 04-24-2025
- PRTA 05-08-2025
- Dividend Yield
- DGICA 3.70%
- PRTA N/A
- EPS Growth
- DGICA 1206.68
- PRTA N/A
- EPS
- DGICA 2.03
- PRTA N/A
- Revenue
- DGICA $993,637,805.00
- PRTA $137,935,000.00
- Revenue This Year
- DGICA $5.29
- PRTA N/A
- Revenue Next Year
- DGICA $5.85
- PRTA $131.71
- P/E Ratio
- DGICA $9.69
- PRTA N/A
- Revenue Growth
- DGICA 5.29
- PRTA 54.55
- 52 Week Low
- DGICA $12.26
- PRTA $8.00
- 52 Week High
- DGICA $20.51
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- DGICA 60.30
- PRTA 24.16
- Support Level
- DGICA $19.39
- PRTA $9.37
- Resistance Level
- DGICA $20.03
- PRTA $8.80
- Average True Range (ATR)
- DGICA 0.67
- PRTA 0.67
- MACD
- DGICA 0.05
- PRTA -0.09
- Stochastic Oscillator
- DGICA 67.22
- PRTA 16.19
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).